SCHEMBL9319237

SCHEMBL9319237

O=C(/C=C/c1ccccc1C(=O)O)c1ccccc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.58
RAB9A P51151 6/20 0.58
NPC1 O15118 5/20 0.58
BCHE P06276 4/20 0.58
LMNA P02545 2/20 0.58
MAOB P27338 3/20 0.58
PLIN1 O60240 1/20 0.58
TNFRSF1A P19438 1/20 0.58
ACHE P22303 1/20 0.58
RECQL P46063 1/20 0.58
PLIN5 Q00G26 1/20 0.58
CYP1B1 Q16678 1/20 0.58
ABHD5 Q8WTS1 1/20 0.58
TYR P14679 1/20 0.54
KMT2A Q03164 5/20 0.51
NFKB1 P19838 3/20 0.51
NFKB2 Q00653 3/20 0.51
RELA Q04206 3/20 0.51
CYP3A4 P08684 2/20 0.51
HSPD1 P10809 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6311040 1.00 MAPT (0.58) MAPTRAB9ANPC1BCHELMNA
SCHEMBL7616179 0.87 BCHE (0.58) MAPTBCHELMNAMAOBKMT2A
SCHEMBL7925836 0.86 MAPT (0.53) MAPTRAB9ANPC1BCHELMNA
SCHEMBL10341680 0.86 MAPT (0.53) MAPTRAB9ANPC1BCHELMNA
SCHEMBL10341679 0.86 MAPT (0.53) MAPTRAB9ANPC1BCHELMNA
SCHEMBL7616189 0.86 MAPT (0.53) MAPTRAB9ANPC1BCHELMNA
SCHEMBL9006476 0.86 MAPT (0.69) MAPTRAB9ANPC1BCHELMNA
SCHEMBL31549899 0.86 RAB9A (0.59) MAPTRAB9ANPC1BCHELMNA
SCHEMBL30791476 0.86 MAPT (0.56) MAPTRAB9ANPC1BCHELMNA
SCHEMBL11652456 0.86 MAPT (0.55) MAPTRAB9ANPC1BCHELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119039135-A Carboxyl chalcone derivative and preparation method and application thereof 四川大学 2024-11-29 CN claimed
US-20260102327-A1 COSMETIC COMPOSITION FOR SKIN IMPROVEMENT CONTAINING LOW-MOLECULAR-WEIGHT COLLAGEN, COLLAGEN WATER, OR COLLAGEN EXTRACT SOOY-K CO., LTD. (KR) 2026-04-16 US disclosed
CN-119039135-B Carboxyl chalcone derivative and preparation method and application thereof 四川大学 2025-10-24 CN disclosed
WO-2025070135-A1 HEXAVALENT-CHROMIUM-REDUCING PHOTOCATALYST COMPOSITION AND METHOD FOR REDUCING HEXAVALENT CHROMIUM ユシロ化学工業株式会社 2025-04-03 WO disclosed
CN-119100965-A Synthesis method of 2, 4-diphenyl pyrrole 南京科技职业学院 2024-12-10 CN disclosed
CN-119039135-A Carboxyl chalcone derivative and preparation method and application thereof 四川大学 2024-11-29 CN disclosed
CN-119039135-A Carboxyl chalcone derivative and preparation method and application thereof 四川大学 2024-11-29 CN disclosed
US-20230415137-A1 PHOTOCATALYST COMPOSITION, PHOTOCATALYST COMPOSITION SOLUTION, PHOTOCATALYST MEMBER, METHOD FOR USING PHOTOCATALYST COMPOSITION, AND SPACE DISINFECTION METHOD YUSHIRO CHEMICAL INDUSTRY CO., LTD. (JP) 2023-12-28 US disclosed
US-5326900-A Aromatic keto compounds, the preparation thereof, and drugs and cosmetics containing these BASF AKTIENGESELLSCHAFT (DE) 1994-07-05 US disclosed
US-5194664-A Aromatic keto compounds, the preparation thereof, and drugs and cosmetics containing these BASF AKTIENGESELLSCHAFT (DE) 1993-03-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260102327-A1 COSMETIC COMPOSITION FOR SKIN IMPROVEMENT CONTAINING LOW-MOLECULAR-WEIGHT COLLAGEN, COLLAGEN WATER, OR COLLAGEN EXTRACT COL2A1, COL14A1, COL1A1 MAPT 3630/4885RAB9A 3962/4885NPC1 4545/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.